Recently, an increasing number of studies have confirmed the involvement of OS and neuroinflammation in MDD pathology.259,260 Two novel biomarkers, serum nicotinamide adenine dinucleotide phosphate oxidase 1 (NOX1) and Raftlin, are reported to have good diagnostic value in MDD patients. Here, RFTN1 is linked to major depressive disorder.